Herzschrittmachervermittelte Tachykardieerkennung und Beendigung in Zweikammer-Herzschrittmachersystemen ohne Elektroden
Anmelder: Pacesetter, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4725544
- Anmeldetag
- 12. September 2025
- Veröffentlichung
- 15. April 2026
- Rechtsraum
- EP
- IPC
- (JIANG CHUNLAN et al.)(FISHLER MATTHEW G et al.)
Abstract
Dual chamber leadless pacemaker systems comprising an atrial leadless pacemaker (aLP) (102) and a ventricular leadless pacemaker (vLP) (104) are disclosed. Such systems can detect and terminate pacemaker mediated tachycardia (PMT) even when the implant-to-implant (i2i) communication from the vLP (104) to aLP (102) (V2A) is compromised. The vLP (104) monitors for PMT in response to reception of an i2i communication from the aLP (102) indicating compromised V2A i2i communication and initiates, following detection of a PMT, initiate a PMT PV interval in response to reception of an i2i communication from the aLP (102) indicating an atrial sensed event. The PMT PV interval is shorter than a PV interval that the vLP (104) would otherwise use for ventricular pacing if PMT was not detected. The vLP (104) also delivers a ventricular pacing pulse to the ventricular cardiac chamber in response to the PMT PV interval expiring without an intrinsic ventricular event being detected during the PMT PV interval.
Anmelder
- Firma
- Pacesetter, Inc.
- Land
- 🇺🇸 USA
US-amerikanisches Unternehmen der Medizintechnik, historisch Hersteller von Herzschrittmachern und implantierbaren Defibrillatoren, später Teil von Abbotts Herzrhythmus-Sparte.
196 Patente in unserer Datenbank
Vertreten von
-
Barker Brettell Sweden AB
Barker Brettell Sweden AB · Stockholm